Strides Pharma Science’s arm acquires USFDA approved manufacturing facility in US
27th Aug 2019

Strides Pharma Science’s step down subsidiary -- Strides Pharma Inc. (SPI) has acquired a US Food and Drug Administration (USFDA) approved manufacturing facility in Florida, US from Micelle BioPharma, Inc.

Micelle’s facility is based in Riviera Beach, Florida and is one of the very few manufacturing facilities in the US with a soft gel capsule (SGC) manufacturing suite for formulations with containment needs. It is also the only FDA approved integrated manufacturing-packaging SGC facility in the US. The site has undergone several successful FDA inspections and has no outstanding FDA observations.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.